Transforming cancer treatment: The potential of nanonutraceuticals
Girish Kumar,
No information about this author
Tarun Virmani,
No information about this author
Vaishnavi Chhabra
No information about this author
et al.
International Journal of Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
667, P. 124919 - 124919
Published: Nov. 7, 2024
Language: Английский
Novel Nanocarriers Microencapsulation: Current, Patents and Clinical Trials Comprehensive Review
Aileen Tressa,
No information about this author
Anshika Singh,
No information about this author
Rahul Pal
No information about this author
et al.
Journal of Drug Delivery and Therapeutics,
Journal Year:
2025,
Volume and Issue:
15(4), P. 188 - 208
Published: April 15, 2025
The
field
of
nanocarriers
and
microencapsulation
has
witnessed
substantial
growth,
offering
innovative
solutions
for
drug
delivery
challenges.
This
comprehensive
review
explores
the
latest
advancements
in
technologies,
focusing
on
their
applications
enhancing
stability,
controlled
release,
targeted
delivery.
article
highlights
key
breakthroughs,
emphasizing
significance
addressing
therapeutic
inefficacies.
A
detailed
analysis
current
patents
underscores
strides
this
domain,
while
insights
into
clinical
trials
provide
a
perspective
translational
potential
these
technologies.
begins
with
fundamental
overview
microencapsulation,
including
its
various
types
characteristics.
It
intermediately
delves
several
formulation
techniques
associated
examining
developments
prepared
formulations,
granted
patents,
selection
marketed
products.
Finally,
addresses
future
prospects
challenges
that
lie
ahead
field.
Keywords:
microencapsulation;
entrapment;
microcapsules;
nanocarriers;
advancements.
Language: Английский
Zwitterionic, Stimuli-Responsive Liposomes for Curcumin Drug Delivery: Enhancing M2 Macrophage Polarization and Reducing Oxidative Stress through Enzyme-Specific and Hyperthermia-Triggered Release
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
A
zwitterionic,
stimuli-responsive
liposomal
system
was
meticulously
designed
for
the
precise
and
controlled
delivery
of
curcumin,
leveraging
enzyme-specific
hyperthermic
stimuli
to
enhance
therapeutic
outcomes.
This
platform
is
specifically
engineered
release
curcumin
in
response
phospholipase
A2,
an
enzyme
that
degrades
phospholipids,
enabling
highly
targeted
site-specific
drug
release.
Mild
hyperthermia
(40
°C)
further
enhances
membrane
permeability
activates
thermosensitive
carriers,
optimizing
delivery.
Curcumin
encapsulation
facilitated
through
a
combination
zwitterionic
electrostatic
interactions,
significantly
improving
both
loading
capacity
efficiency.
design
experiments
(DoE)
approach
employed
systematically
optimize
lipid-to-cholesterol
ratios
formulation
conditions.
The
thoroughly
characterized
using
dynamic
light
scattering,
zeta
potential
measurements,
transmission
electron
microscopy,
ensuring
stability
structural
integrity.
Notably,
this
effectively
encapsulates
hydrophobic
while
maintaining
particle
size
bioactivity.
In
vitro
studies
revealed
robust
antioxidant
anti-ROS
activities,
alongside
excellent
biocompatibility,
with
no
cytotoxicity
observed
at
concentrations
up
2000
μg/mL.
Furthermore,
liposomes
enhanced
M2
macrophage
polarization
reduced
oxidative
stress.
advanced
offers
promising,
biocompatible
solution
Language: Английский